Eastman Chemical (EMN) Director Awarded Phantom Stock Units
EASTMAN CHEMICAL CO
Subscribe to track EMN
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Eastman Chemical (EMN) Director Awarded Phantom Stock Units
Company: EASTMAN CHEMICAL CO (EMN) Form: 4 | Filed: 2025-10-09 Significance: Low
Insider: OBRIEN JAMES J /KY Title: null | Relationship: Director
Transaction: • Type: Grant • Shares: 487 Phantom Stock Units • Price: $0.00 • Value: $0 • Owned After: 17,407 units
Key Insight: A director was awarded phantom stock units as part of a deferred compensation plan. This is a routine compensation event, not an open-market purchase, and has low trading significance.
Market Context: The transaction represents the automatic deferral of a portion of the director's annual retainer fees into stock-equivalent units, a common practice for board compensation.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: EASTMAN CHEMICAL CO (EMN)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director received a routine grant of phantom stock units as part of their deferred compensation plan. This is not an open-market transaction and does not signal a new investment decision by the insider.
- Market Impact: Neutral. This type of compensatory grant is standard and is not expected to influence market sentiment or trading volume.
Company Information
| Field | Value |
|---|---|
| Company | EASTMAN CHEMICAL CO |
| Ticker Symbol | EMN |
| CIK | 0000915389 |
| Industry | PLASTICS, MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS [2821] |
Insider Information
| Field | Value |
|---|---|
| Name | OBRIEN JAMES J /KY |
| CIK | 0001023582 |
| Title/Position | null |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-10-07 |
| Transaction Code | A (Award) |
| Security Type | Phantom Stock Units |
| Shares Involved | 487 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 17,407 |
| Ownership Type | Direct |
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction is a non-cash award related to director compensation. It does not represent a new capital commitment by the insider and is a scheduled, automatic event. The market typically does not react to such routine filings.
Volume & Sentiment
- Expected Volume Impact: None. This is a non-market transaction and will not affect trading volume.
- Sentiment Indicator: Neutral. The filing confirms the company's director compensation plan is functioning as disclosed but provides no new bullish or bearish signal.
Investment Insights
Positive Market Indicators
- Aligning Interests: Compensating directors with stock-based units (even phantom stock) helps align their interests with those of shareholders.
Risk Factors
- Not a Cash Investment: This is not a purchase made with the insider's own capital on the open market. It should not be interpreted as a signal of newfound confidence in the company's prospects.
Key Takeaways
- Routine Compensation: The acquisition of 487 phantom stock units is an automatic deferral of director fees, as noted in the filing's footnotes.
- Cash-Settled Derivative: The phantom stock units are payable only in cash upon termination of service, meaning they are not convertible into common stock.
- No Market Signal: With a transaction price of $0, this filing is purely informational regarding director compensation and carries no investment signal.
Contextual Analysis
Timing Significance
This transaction is tied to the director's compensation schedule and is not timed based on market conditions or inside information. Its significance is administrative rather than strategic.
Transaction Context
Footnote F2 clarifies the nature of the transaction: "Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan, which would otherwise have been paid in cash." This confirms it is a planned, non-discretionary event.
Company Context
This filing should be viewed in the context of Eastman Chemical's standard corporate governance and executive compensation practices. It does not relate to any specific operational or financial news.
Risk Assessment
Risk Level: Low
Risk Factors
- Misinterpretation: The primary risk is an investor misinterpreting this routine compensation filing as a bullish insider purchase.
- No Skin in the Game: This specific transaction does not represent a new cash investment from the director.
Market Considerations
- Focus on Fundamentals: Investors should continue to focus on the company's financial performance, industry trends, and strategic initiatives rather than this administrative filing.
- Compensation Structure: The filing provides minor insight into the company's board compensation structure.
IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.
Analysis generated on 2025-10-09 | Data source: SEC EDGAR
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.